This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Corporate/International Tax Alert (5/11/2010)

Tax authorities issue administrative circular on accounting and tax treatment of R&D tax credit

Introduction 

The Belgian tax authorities published an administrative circular that includes numerical examples of how the R&D tax credit must be applied for accounting and tax purposes (Administrative Circular Ci.RH.421/579.072 (AOIF 60/2010) of 10 September 2010). 

Since the booking of the R&D credit may not impact the taxable basis, the tax authorities give an overview of how this tax neutrality is achieved through the appropriate accounting treatment and tax adjustments. 

R&D tax credit 

The tax credit for investments in R&D was introduced as from tax year 2007 as an alternative to the increased investment deduction for R&D. 

As is the case for the investment deduction, the tax credit can be applied as a one-time credit or as rollover relief, depending on the nature of the asset in which the investment is made. The R&D credit is fully creditable against the corporate tax or nonresident corporate tax, with any excess credit available to be carried forward to the four following tax years (up to a set amount). Excess credit remaining after the fifth tax year is reimbursed. 

Administrative circular 

The administrative circular illustrates the accounting and tax treatment of the R&D tax credit in the following situations: 

  • One-time R&D tax credit; 
  • Rollover R&D tax credit; 
  • Loss of the R&D tax credit where there is a change in control or a restructuring when there was no legitimate economic or financial need for the transaction. 

Technically, tax neutrality is achieved in the following ways:

  • The tax credit should be recognized in the accounts through a #7 account (on the credit side) and a # 491 account (on the debit side);
  • The use of the tax credit should be booked via account #67 of the profit and loss account and is not considered a disallowed item for corporate income tax purposes; 
  • An amount equal to the amount that cannot be credited against the corporate tax is added as a negative taxed reserve at the end of the taxable period to compensate for the unused tax credit booked in the #7 account and reported in the #491 account; 
  • In case of a reimbursement of the tax credit, the beginning position of the taxable reserves is increased for the same amount as a result of the reduction of the negative taxed reserves and a #412 account would be debited. 

Conclusion 

The R&D tax credit is a viable alternative to the R&D investment deduction. The new administrative circular provides useful guidelines for correctly booking this benefit and reporting it in the tax return.

Contacts

Name:
Patrick Brauns
Company:
Deloitte Belgium
Job Title:
Partner Tax
Phone:
Email
pbrauns@deloitte.com
Name:
Renaud Hendricé
Company:
Deloitte Belgium
Job Title:
Partner Tax
Phone:
Email
rhendrice@deloitte.com

Email Us Facebook Twitter Youtube LinkedIn Corporate LinkedIn Alumni Flickr

Material on this website is © 2013 Deloitte Global Services Limited, or a member firm of Deloitte Touche Tohmatsu Limited, or one of their affiliates. See Legal for copyright and other legal information.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.

Get connected

 

More on Deloitte
Learn about our site